News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Bax24 data boost baxdrostat potential for resistant HTN
21 Apr 2026
byAudrey Abella
The results of the phase III Bax24 trial underpin the efficacy of baxdrostat, a selective aldosterone synthase inhibitor (ASI), for the treatment of uncontrolled or resistant hypertension (HTN).
Bax24 data boost baxdrostat potential for resistant HTN
21 Apr 2026
Is vaginal laser the answer to SUI in women?
20 Apr 2026
byStephen Padilla
Women with stress urinary incontinence (SUI) who undergo vaginal lasers do not seem to fare any better than those who received sham, control, or topical treatments in the short term, suggests a study.






